In this talk, I will discuss the OpenNeuro Fitlins GLM package and provide an illustration of the analytic workflow. OpenNeuro FitLins GLM is a semi-automated pipeline that reduces barriers to analyzing task-based fMRI data from OpenNeuro's 600+ task datasets. Created for psychology, psychiatry and cognitive neuroscience researchers without extensive computational expertise, this tool automates what is largely a manual process and compilation of in-house scripts for data retrieval, validation, quality control, statistical modeling and reporting that, in some cases, may require weeks of effort. The workflow abides by open-science practices, enhancing reproducibility and incorporates community feedback for model improvement. The pipeline integrates BIDS-compliant datasets and fMRIPrep preprocessed derivatives, and dynamically creates BIDS Statistical Model specifications (with Fitlins) to perform common mass univariate [GLM] analyses. To enhance and standardize reporting, it generates comprehensive reports which includes design matrices, statistical maps and COBIDAS-aligned reporting that is fully reproducible from the model specifications and derivatives. OpenNeuro Fitlins GLM has been tested on over 30 datasets spanning 50+ unique fMRI tasks (e.g., working memory, social processing, emotion regulation, decision-making, motor paradigms), reducing analysis times from weeks to hours when using high-performance computers, thereby enabling researchers to conduct robust single-study, meta- and mega-analyses of task fMRI data with significantly improved accessibility, standardized reporting and reproducibility.

Britta Engelhard’s research is devoted to understanding thefunction of the different brain barriers in regulating CNS immunesurveillance and how their impaired function contributes toneuroinflammatory diseases such as Multiple Sclerosis (MS) orAlzheimer’s disease (AD). Her laboratory combines expertise invascular biology, neuroimmunology and live cell imaging and hasdeveloped sophisticated in vitro and in vivo approaches to studyimmune cell interactions with the brain barriers in health andneuroinflammation.

Large-scale recordings of neural activity are providing new opportunities to study network-level dynamics with unprecedented detail. However, the sheer volume of data and its dynamical complexity are major barriers to uncovering and interpreting these dynamics. I will present latent factor analysis via dynamical systems, a sequential autoencoding approach that enables inference of dynamics from neuronal population spiking activity on single trials and millisecond timescales. I will also discuss recent adaptations of the method to uncover dynamics from neural activity recorded via 2P Calcium imaging. Finally, time permitting, I will mention recent efforts to improve the interpretability of deep-learning based dynamical systems models.

Building upon the webinar "What are the main barriers to succeed in brain sciences in Latin America?" (February 2021) and the paper "Addressing the opportunity gap in the Latin American neuroscience community" (Silva, A., Iyer, K., Cirulli, F. et al. Nat Neurosci August 2022), this ALBA-IBRO Webinar is the next chapter in our journey towards fostering inclusivity and diversity in neuroscience in Latin America. The webinar is designed to go beyond theoretical discussions and provide tangible solutions. We will showcase 3-4 best practice case studies, shining a spotlight on real-life actions and campaigns implemented at the institutional level, be it within government bodies, universities, or other organisations. Our goal is to empower neuroscientists across Latin America by equipping them with practical knowledge they can apply in their own institutions and countries.

Clinical assessment of consciousness is a significant issue, with recent research suggesting some brain-damaged patients who are assessed as unconscious are in fact conscious. Misdiagnosis of consciousness can also be detrimental when it comes to general anaesthesia, causing numerous psychological problems, including post-traumatic stress disorder. Avoiding awareness with overdose of anaesthetics, however, can also lead to cognitive impairment. Currently available objective assessment of consciousness is limited in accuracy or requires expensive equipment with major barriers to translation. In this talk, we will outline our recent theory-guided and data-driven approaches to develop new, optimized consciousness measures that will be robustly evaluated on an unprecedented breadth of high-quality neural data, recorded from the fly model system. We will overcome the subjective-choice problem in data-driven and theory-guided approaches with a comprehensive data analytic framework, which has never been applied to consciousness detection, integrating previously disconnected streams of research in consciousness detection to accelerate the translation of objective consciousness measures into clinical settings.

Over the last few decades, the use of deep brain stimulation (DBS) to improve the treatment of those with neurological movement disorders represents a critical success story in the development of invasive neurotechnology and the promise of brain-computer interfaces (BCI) to improve the lives of those suffering from incurable neurological disorders. In the last decade, investigational devices capable of recording and streaming neural activity from chronically implanted therapeutic electrodes has supercharged research into clinical applications of BCI, enabling in-human studies investigating the use of adaptive stimulation algorithms to further enhance therapeutic outcomes and improve future device performance. In this talk, Dr. Herron will review ongoing clinical research efforts in the field of adaptive DBS systems and algorithms. This will include an overview of DBS in current clinical practice, the development of bidirectional clinical-use research platforms, ongoing algorithm evaluation efforts, a discussion of current adoption barriers to be addressed in future work.

Large-scale recordings of neural activity are providing new opportunities to study network-level dynamics with unprecedented detail. However, the sheer volume of data and its dynamical complexity are major barriers to uncovering and interpreting these dynamics. I will present machine learning frameworks that enable inference of dynamics from neuronal population spiking activity on single trials and millisecond timescales, from diverse brain areas, and without regard to behavior. I will then demonstrate extensions that allow recovery of dynamics from two-photon calcium imaging data with surprising precision. Finally, I will discuss our efforts to facilitate comparisons within our field by curating datasets and standardizing model evaluation, including a currently active modeling challenge, the 2021 Neural Latents Benchmark [neurallatents.github.io].

For the first time, we are holding a NMC around the globe session, a panel of computational neuroscientists working in different continents who are willing to discuss their challenges and milestones in doing science and training researchers in their home country. We hope that our panelists can share their barriers, what they define as accomplishments and how they would like the future of computational neuroscience to evolve locally and internationally with our diverse NMC audience.

Our first NeurotechEU Summit will be fully digital and will take place on November 22th from 09:00 to 17:00 (CET). The final programme can be downloaded here. Hosted by the Karolinska Institutet, the summit will provide you an overview of our actions and achievements from the last year and introduce the priorities for the next year. You will also have the opportunity to attend the finals of the 3 minute thesis competition (3MT) organized by the Synapses Student Society, the student charter of NeurotechEU. Good luck to all the finalists: Lynn Le, Robin Noordhof, Adriana Gea González, Juan Carranza Valencia, Lea van Husen, Guoming (Tony) Man, Lilly Pitshaporn Leelaarporn, Cemre Su, Kaya Keleş, Ramazan Tarık Türksoy, Cristiana Tisca, Sara Bandiera, Irina Maria Vlad, Iulia Vadan, Borbála László, and David Papp! Don’t miss our keynote lecture, success stories and interactive discussions with Ms Vanessa Debiais Sainton (Head of Higher Education Unit, European Commission), Prof. Staffan Holmin (Karolinska Institutet), Dr Mohsen Kaboli (BMW Group, member of the NeurotechEU Associates Advisory Committee), and Prof. Peter Hagoort (Max Planck Institute for Psycholinguistics, Donders Institute). Would you like to use this opportunity to network? Please join our informal breakout sessions on Wonder.me at 11:40 CET. You will be able to move from one discussion group to another within 3 sessions: NeurotechEU ecosystem - The Associates Advisory Committee: Synergies in cross-sectoral initiatives Education next: Trans-European education and the European Universities Initiatives - Lessons learned thus far. Equality, diversity and inclusion at NeurotechEU: removing access barriers to education and developing a working, learning, and social environment where everyone is respected and valued. You can register for this free event at www.crowdcast.io/e/neurotecheu-summit

One of the most important questions in psychology and neuroscience is understanding how the outside world maps to internal representations. Classical psychophysics approaches to this problem have a number of limitations: they mostly study low dimensional perpetual spaces, and are constrained in the number and diversity of participants and experiments. As ecologically valid perception is rich, high dimensional, contextual, and culturally dependent, these impediments severely bias our understanding of perceptual representations. Recent technological advances—the emergence of so-called “Virtual Labs”— can significantly contribute toward overcoming these barriers. Here I present a number of specific strategies that my group has developed in order to probe representations across a number of dimensions. 1) Massive online experiments can increase significantly the amount of participants and experiments that can be carried out in a single study, while also significantly diversifying the participant pool. We have developed a platform, PsyNet, that enables “experiments as code,” whereby the orchestration of computer servers, recruiting, compensation of participants, and data management is fully automated and every experiment can be fully replicated with one command line. I will demonstrate how PsyNet allows us to recruit thousands of participants for each study with a large number of control experimental conditions, significantly increasing our understanding of auditory perception. 2) Virtual lab methods also enable us to run experiments that are nearly impossible in a traditional lab setting. I will demonstrate our development of adaptive sampling, a set of behavioural methods that combine machine learning sampling techniques (Monte Carlo Markov Chains) with human interactions and allow us to create high-dimensional maps of perceptual representations with unprecedented resolution. 3) Finally, I will demonstrate how the aforementioned methods can be applied to the study of perceptual priors in both audition and vision, with a focus on our work in cross-cultural research, which studies how perceptual priors are influenced by experience and culture in diverse samples of participants from around the world.

Human participant research is somehow both antithetical and complementary to science. On the one hand, working with human participants provides incredibly rich and complex data with ‘real-world’ ecological validity. On the other, this richness is due to the incredible number of variables which uncontrollably become intertwined with your research interest, potentially limiting the conclusions you can draw from your work. Historical over-representation of white men as research participants, coupled with often overly-stringent exclusion criteria has led to a diversity crisis in human participant research. For our research to be truly inclusive, representative and generalisable to the rest of the population, our data must be collected from diverse individuals. This session will explore common barriers to diversity in studies with human participants, and will provide guidance on how to make sure your own research is accessible and inclusive.

How can neural networks exhibit persistent activity on time scales much larger than allowed by cellular properties? We address this question in the context of larval zebrafish, a model vertebrate that is accessible to brain-scale neuronal recording and high-throughput behavioral studies. We study in particular the dynamics of a bilaterally distributed circuit, the so-called ARTR, including hundreds neurons. ARTR exhibits slow antiphasic alternations between its left and right subpopulations, which can be modulated by the water temperature, and drive the coordinated orientation of swim bouts, thus organizing the fish spatial exploration. To elucidate the mechanism leading to the slow self-oscillation, we train a network graphical model (Ising) on neural recordings. Sampling the inferred model allows us to generate synthetic oscillatory activity, whose features correctly capture the observed dynamics. A mean-field analysis of the inferred model reveals the existence several phases; activated crossing of the barriers in between those phases controls the long time scales present in the network oscillations. We show in particular how the barrier heights and the nature of the phases vary with the water temperature.

The Chiu laboratory focuses on neuro-immune interactions in pain, itch, and tissue inflammation. Dr. Chiu’s research has uncovered molecular interactions between the nervous system, the immune system and microbes that modulates host defense. He has found that sensory neurons can directly detect bacterial pathogens and their toxins to produce pain. Neurons in turn release neuropeptides that modulate immune cells in host defense. These interactions occur at major tissue barriers in the body including the gut, skin and lungs. In this talk, he will discuss these major neuro-immune interactions and how understanding them could lead to novel approaches to treat pain or inflammation.